You are here: Industry Insights > vaccine

News List

Study Confirms That Black People Are at Higher Risk for COVID-19, and Reveals That Affluent Whites Are Also at High Risk prnewswire
July 09, 2021
Breaking research published in AACC's The Journal of Applied Laboratory Medicine has found that, at the start of the pandemic, the two demographic groups most likely to get COVID-19 were low socioeconomic status Black people and high socioeconomic status.
Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development firstwordpharma
July 08, 2021
Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.
Vaccine Stocks Skid As Delta Variant Becomes More Prevalent U.S. Covid Strain firstwordpharma
July 08, 2021
Stocks of COVID-19 vaccine developers skidded on Wednesday after the US Centers for Disease Control and Prevention (CDC) indicated that the highly transmissible Delta variant makes up close to 52% of cases in the country, reported Investor's Business Dail
Huons acquires marketing rights for Sputnik Light in S. Korea firstwordpharma
July 08, 2021
Huons Global has secured marketing rights for Russia's COVID-19 vaccine Sputnik Light in South Korea, said The Korea Herald.
COVID Vaccine Doesn't Infiltrate Breast Milk drugs
July 07, 2021
Women who are breastfeeding and wonder if COVID-19 vaccination is safe for their baby may be reassured by the results of a new study.
Recipharm selected to operate new fill/finish facility in Morocco cphi-online
July 07, 2021
Move is part of US$500 million five-year investment programme by Moroccan government and consortium to establish vaccine and biotherapeutic manufacturing capacity in the country
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine Candidate prnewswire
July 07, 2021
Dynavax Technologies Corporation today announced the execution of a commercial supply agreement of Dynavax's CpG 1018TM advanced adjuvant, for use in BE's subunit COVID-19 vaccine candidate, CORBEVAX™.
Researchers find potential path to a broadly protective COVID-19 vaccine using T cells firstwordpharma
July 06, 2021
Gaurav Gaiha, MD, DPhil, a member of the Ragon Institute of MGH, MIT and Harvard, studies HIV, one of the fastest-mutating viruses known to humankind.
Ministry data said to show Pfizer shot blocks majority of serious Delta cases firstwordpharma
July 06, 2021
A study from researchers at Hebrew University and Hadassah University Medical Center suggest Pfizer and BioNTech's COVID-19 vaccine is 60% to 80% effective against infection from the Delta variant, reported The Times of Israel.
Gap between Covid jabs to be reduced to eight weeks for all under-40s firstwordpharma
July 06, 2021
New UK health secretary Sajid Javid told lawmakers "we are reducing the dose interval [for COVID-19 vaccines] for under-40s from 12 weeks to eight," as reported in This is Money.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page